CSLM Acquisition Corporation News - CSLMR

BHP Sees Development Options to Lift Petroleum Output

By Robb M. Stewart MELBOURNE, Australia--BHP Group Ltd. (BHP.AU) has flagged a number of projects that could boost its oil production and help the...

ADRs End Slightly Higher; Santander, Embraer Actively

International stocks trading in New York closed slightly higher on Thursday. The BNY Mellon index of American depositary receipts rose 0.7% to...

Benitec Establishes A Sponsored US ADR Program

Benitec Establishes A Sponsored US ADR Program PR Newswire SYDNEY, May 30, 2014 SYDNEY, May 30, 2014 /PRNewswire/ -- Benitec Biopharma Limited...

Benitec Commences Patient Dosing With TT-034 In Patients With Hepatitis C

Benitec Commences Patient Dosing With TT-034 In Patients With Hepatitis C PR Newswire SYDNEY, May 29, 2014 SYDNEY, May 29, 2014 /PRNewswire/...

European Patents Update

European Patents Update PR Newswire THE HAGUE, The Netherlands, May 22, 2014 -- Outcome of EPO opposition hearing -- Benitec executes license...

European Patents Update

European Patents Update -- Outcome of EPO opposition hearing -- Benitec executes license from Galapagos NV for RNAi in Europe PR Newswire THE...

Benitec Biopharma Completes AUD $31.5 million Private Placement

Benitec Biopharma Completes AUD $31.5 million Private Placement Shareholders Overwhelmingly Approve Second AUD $15.7 million Tranche Following...

Benitec Biopharma Announces Private Placement of Ordinary Shares and Warrants

Benitec Biopharma Announces Private Placement of Ordinary Shares and Warrants Company to Receive up to approximately AUD $31.5 million to...

HCV clinical trial application submitted to Recombinant DNA Advisory Committee (RAC)

HCV clinical trial application submitted to Recombinant DNA Advisory Committee (RAC) -- Benitec progresses hepatitis C therapeutic towards the...

Benitec Selects University of California, San Diego as a Site for Phase I/II Clinical Trial of TT-034 in Patients with Hepati...

Benitec Selects University of California, San Diego as a Site for Phase I/II Clinical Trial of TT-034 in Patients with Hepatitis C Infections PR...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

CSLM Acquisition Corporation (CSLMR)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

CSLMR News

BHP Sees Development Options to Lift Petroleum Output

ADRs End Slightly Higher; Santander, Embraer Actively

Benitec Establishes A Sponsored US ADR Program

Benitec Commences Patient Dosing With TT-034 In Patients With Hepatitis C

European Patents Update

European Patents Update

Benitec Biopharma Completes AUD $31.5 million Private Placement

Benitec Biopharma Announces Private Placement of Ordinary Shares and Warrants

HCV clinical trial application submitted to Recombinant DNA Advisory Committee (RAC)

Benitec Selects University of California, San Diego as a Site for Phase I/II Clinical Trial of TT-034 in Patients with Hepati...

Appointment of Mr. Kevin Buchi to Benitec Board

Benitec Selects the Duke Clinical Research Unit as a Site for Hepatitis C Phase I/II Clinical Trial

uniQure Licenses RNA Interference Technology to Advance Huntington's Disease Program

Benitec Raises AU$8 million to Forge Ahead with its Gene Silencing Therapeutics: Rights Issue Closes Oversubscribed

Patent Update: Strengthening and Expansion of Benitec’s Dominant Patent Position in RNAi

CSLMR Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

CSLM Acquisition Corporation (CSLMR) News

CSLM Acquisition Corporation (CSLMR)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

CSLMR News

BHP Sees Development Options to Lift Petroleum Output

ADRs End Slightly Higher; Santander, Embraer Actively

Benitec Establishes A Sponsored US ADR Program

Benitec Commences Patient Dosing With TT-034 In Patients With Hepatitis C

European Patents Update

European Patents Update

Benitec Biopharma Completes AUD $31.5 million Private Placement

Benitec Biopharma Announces Private Placement of Ordinary Shares and Warrants

HCV clinical trial application submitted to Recombinant DNA Advisory Committee (RAC)

Benitec Selects University of California, San Diego as a Site for Phase I/II Clinical Trial of TT-034 in Patients with Hepati...

Appointment of Mr. Kevin Buchi to Benitec Board

Benitec Selects the Duke Clinical Research Unit as a Site for Hepatitis C Phase I/II Clinical Trial

uniQure Licenses RNA Interference Technology to Advance Huntington's Disease Program

Benitec Raises AU$8 million to Forge Ahead with its Gene Silencing Therapeutics: Rights Issue Closes Oversubscribed

Patent Update: Strengthening and Expansion of Benitec’s Dominant Patent Position in RNAi

CSLMR Discussion

Your Recent History